|1.||Matsushima, K: 4 articles (08/2007 - 04/2000)|
|2.||Lipp, Martin: 3 articles (01/2014 - 09/2006)|
|3.||Sharma, Sherven: 3 articles (01/2011 - 04/2004)|
|4.||Dubinett, Steven M: 3 articles (01/2011 - 04/2004)|
|5.||Wu, Jian: 3 articles (12/2008 - 11/2007)|
|6.||Husberg, Cathrine: 2 articles (01/2014 - 01/2012)|
|7.||Yndestad, Arne: 2 articles (01/2014 - 01/2012)|
|8.||Ueland, Thor: 2 articles (01/2014 - 01/2012)|
|9.||Finsen, Alexandra Vanessa: 2 articles (01/2014 - 01/2012)|
|10.||Dahl, Christen P: 2 articles (01/2014 - 01/2012)|
|1.||Melanoma (Melanoma, Malignant)
01/01/2007 - "Here, we report that intratumoral expression of the chemokine CCL21 enhances the efficacy of adoptive T-cell therapy in a mouse model of melanoma. "
04/01/2004 - "CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells."
01/01/2001 - "Melanoma-conditioned DC exhibited an increased adhesion capacity to a melanoma cell line in vitro and did not migrate in response to SLC chemokine. "
01/01/2015 - "The presence of lymph node (LN)-like vasculature in tumours, characterized by expression of peripheral node addressin and chemokine CCL21, is correlated with T-cell infiltration and positive prognosis in breast cancer and melanoma patients. "
10/01/2011 - "As appropriate interaction of tumor-specific T cells and mature dendritic cells, equipped with tumor antigens, is a prerequisite for effective T cell immunity against established tumors, we mobilized lymphocytes and dendritic cells to tumor sites by intratumoral injection of secondary lymphoid tissue chemokine-Fc (SLC-Fc) fusion protein using the B16F10 murine melanoma model. "
06/01/2007 - "Previous studies have shown that secondary lymphoid chemokine, CCL21, can be used for modulation of tumor-specific immune responses. "
01/01/2014 - "The secondary lymphoid tissue chemokine (CCL21) is closely associated with lymphoid homing and anti-tumor immune responses. "
10/01/2013 - "To explore the anti-tumor effect and immune mechanism mediated by a new recombinant adeno-associated virus (rAAV) encoding secondary lymphoid tissue chemokine (SLC) mature peptide gene. "
01/01/2013 - "Secondary lymphoid tissue chemokine (SLC) is a key CC chemokine for chemotaxis of immune cells and has been an attractive candidate for anti-tumor treatments. "
03/01/2011 - "In agreement with recent reports, expression of the chemokine CCL21 is enhanced after MG/MP activation and correlates with tumor growth. "
|3.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/01/2011 - "Based on our preclinical findings, we are assessing the efficacy of intratumoral injection of dendritic cells (DC) transduced with an adenoviral vector expressing the secondary lymphoid chemokine (CCL21) gene (Ad-CCL21-DC) in a phase I trial in advanced non-small cell lung cancer (NSCLC). "
01/15/2015 - "Previous studies proposed that reduced T cell responses during coinfections are due to diminished recruitment of naive T cells through infection-induced decreases in chemokine CCL21. "
07/01/2011 - "Injury, infection and autoimmune triggers increase CNS expression of the chemokine CCL21. "
01/01/2008 - "The migration of Rv and S7 infected MoDC towards secondary lymphoid chemokine (CCL21) was 50% lower after 1 day of infection compared to LPS stimulation. "
11/01/2007 - "Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections."
03/01/2006 - "MCMV infection caused a specific, but transient transcriptional suppression of secondary lymphoid chemokine (CCL21). "
03/15/2006 - "The antitumor efficiency of dendritic cells transduced with an adenovirus vector expressing secondary lymphoid chemokine (CCL21) was evaluated in a murine model of spontaneous bronchoalveolar cell carcinoma. "
01/01/2004 - "C26 colon carcinoma tumour cell line transduced with CCL21/SLC/6Ckine showed reduced tumorigenicity when injected in vivo into immunocompetent mice. "
08/15/2000 - "These dual properties of mouse 6Ckine/SLC were tested for the induction of an antitumor response by transducing the C26 colon carcinoma tumor cell line with a cDNA encoding mouse 6Ckine/SLC. "
05/15/2002 - "In this study, we found that 4 of 6 (67%) gastric carcinoma cell lines tested expressed functional CCR7 for the chemokine CCL21/6Ckine, as demonstrated by calcium mobilization and actin polymerization assays. "
04/01/2004 - "To establish a more efficient treatment for immunotherapy against solid tumors, we have evaluated the antitumor effect by coexpression of a chemokine CCL21/secondary lymphoid tissue chemokine and a costimulatory molecule LIGHT in colon carcinoma C26. "
|2.||Interleukin-12 (IL 12)
|5.||CD40 Ligand (CD40L)
|6.||Membrane Proteins (Integral Membrane Proteins)
|7.||Folic Acid (Vitamin M)
|3.||Drug Therapy (Chemotherapy)